Liposomal bupivacaine administration is not superior to traditional periarticular injection for postoperative pain management following total knee arthroplasty: a meta-analysis of randomized controlled trials

BACKGROUND: Liposomal bupivacaine (LB) is a relatively new formulation that slowly releases bupivacaine to extend its efficacy for 72–96 h. It is inconclusive whether LB offers better efficacy than traditional periarticular injection (TPAI) following total knee arthroplasty (TKA). METHODS: Relevant...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jian-Jiun, Wu, Yun-Che, Wang, Jun-Sing, Lee, Cheng-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018851/
https://www.ncbi.nlm.nih.gov/pubmed/36922892
http://dx.doi.org/10.1186/s13018-023-03699-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018851/
https://www.ncbi.nlm.nih.gov/pubmed/36922892
http://dx.doi.org/10.1186/s13018-023-03699-4

Ejemplares similares